2017 Guidelines for the management of heart failure by pharmacists.
作者信息
Beique Lesley C, Ezekowitz Justin A, O'Meara Eileen, McDonald Michael, Koshman Sheri L
机构信息
Faculty of Pharmacy and Pharmaceutical Science (Beique), University of Alberta, Edmonton, Alberta.
Division of Cardiology (Ezekowitz, Koshman), University of Alberta, Edmonton, Alberta.
出版信息
Can Pharm J (Ott). 2019 Jul 2;152(5):301-316. doi: 10.1177/1715163519853307. eCollection 2019 Sep-Oct.
Abstract
摘要
相似文献
1
2017 Guidelines for the management of heart failure by pharmacists.药剂师心力衰竭管理2017指南。
Can Pharm J (Ott). 2019 Jul 2;152(5):301-316. doi: 10.1177/1715163519853307. eCollection 2019 Sep-Oct.
2
Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.药剂师在心力衰竭患者出院后管理中的作用：一项文献综述。
J Clin Pharm Ther. 2007 Aug;32(4):343-52. doi: 10.1111/j.1365-2710.2007.00827.x.
3
Current guidelines for treatment of heart failure: 2006 update.心力衰竭治疗的当前指南：2006年更新版。
Pharmacotherapy. 2007 Apr;27(4 Pt 2):12S-17S. doi: 10.1592/phco.27.4part2.12S.
4
Upcoming Challenges in Multidisciplinary Heart Failure Management: Active Role of Future Clinical Pharmacists.多学科心力衰竭管理中的未来挑战：未来临床药师的积极作用
Clin Pharmacol Ther. 2017 Aug;102(2):180-182. doi: 10.1002/cpt.728. Epub 2017 Jun 5.
5
Clinical and economic implications of new strategies for heart failure management in the managed care setting.管理式医疗环境中心力衰竭管理新策略的临床和经济影响。
Pharmacotherapy. 2007 Apr;27(4 Pt 2):29S-32S. doi: 10.1592/phco.27.4part2.29S.
6
Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan.约旦医生和药剂师对醛固酮拮抗剂在心力衰竭和心肌梗死方面的认知情况。
Pharm Pract (Granada). 2017 Jul-Sep;15(3):994. doi: 10.18549/PharmPract.2017.03.994. Epub 2017 Sep 3.
7
Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.心力衰竭的临床药学服务：美国心力衰竭学会和美国临床药学学院心脏病学实践与研究网络的意见文件。
J Card Fail. 2013 May;19(5):354-69. doi: 10.1016/j.cardfail.2013.02.002. Epub 2013 Apr 6.
8
Care transitions in elderly heart failure patients: current practices and the pharmacist's role.老年心力衰竭患者的照护过渡：当前实践与药剂师的作用
Consult Pharm. 2014 Mar;29(3):179-90. doi: 10.4140/TCP.n.2014.179.
9
Underutilization of evidence-based therapies in heart failure: the pharmacist's role.心力衰竭中基于证据的疗法未得到充分利用：药剂师的作用。
Pharmacotherapy. 2007 Apr;27(4 Pt 2):18S-28S. doi: 10.1592/phco.27.4part2.18S.
10
A competency framework for clinical pharmacists and heart failure.临床药师与心力衰竭的能力框架
Int J Pharm Pract. 2019 Oct;27(5):424-435. doi: 10.1111/ijpp.12465. Epub 2018 Jul 20.
引用本文的文献
1
Correlation between the prognostic nutritional index and outcomes in older patients aged ≥ 60 years with chronic heart failure.≥60岁老年慢性心力衰竭患者预后营养指数与预后的相关性
Int J Clin Pharm. 2023 Feb;45(1):163-173. doi: 10.1007/s11096-022-01501-9. Epub 2022 Nov 15.
本文引用的文献
1
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.《加拿大心血管学会心力衰竭管理指南2017年综合更新》
Can J Cardiol. 2017 Nov;33(11):1342-1433. doi: 10.1016/j.cjca.2017.08.022. Epub 2017 Sep 6.
2
Impact of a Pharmacist-Managed Heart Failure Postdischarge (Bridge) Clinic for Veterans.药师管理的退伍军人心力衰竭出院后（过渡）诊所的影响。
Ann Pharmacother. 2017 Jul;51(7):555-562. doi: 10.1177/1060028017698974. Epub 2017 Mar 9.
3
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.卡格列净与 2 型糖尿病的心血管和肾脏事件。
N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.
4
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净：在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
5
Impact of a Multidisciplinary Heart Failure Post-hospitalization Program on Heart Failure Readmission Rates.多学科心力衰竭住院后项目对心力衰竭再入院率的影响。
Ann Pharmacother. 2015 Nov;49(11):1189-96. doi: 10.1177/1060028015599637. Epub 2015 Aug 10.
6
Development of a collaborative transitions-of-care program for heart failure patients.为心力衰竭患者制定一项协作式护理过渡计划。
Am J Health Syst Pharm. 2015 Jul 1;72(13):1147-52. doi: 10.2146/ajhp140563.
7
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.《加拿大心血管学会心房颤动管理指南2014年重点更新》
Can J Cardiol. 2014 Oct;30(10):1114-30. doi: 10.1016/j.cjca.2014.08.001. Epub 2014 Aug 13.
8
Angiotensin-neprilysin inhibition versus enalapril in heart failure.血管紧张素-脑啡肽酶抑制剂与依那普利治疗心力衰竭的比较。
N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
9
The pharmacist role in predicting and improving medication adherence in heart failure patients.药师在预测和改善心力衰竭患者药物依从性中的作用。
J Manag Care Spec Pharm. 2014 Jul;20(7):741-55. doi: 10.18553/jmcp.2014.20.7.741.
10
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.沙格列汀与 2 型糖尿病患者的心血管结局。
N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.
Zotero 插件